ZNF165 and cancer: Like most of the other CT antigens capable of inducing the humoral immune response and the cellular immune response in a minor proportion and a considerable proportion of cancer patients, respectively (Jager et al, 2001; Kirkin et al, 2002), the ZNF165 antigen spontaneously elicited antibody response detected in approximately 5% of HCC patients.